136 related articles for article (PubMed ID: 21094678)
1. Well differentiated follicular thyroid neoplasia: impact of molecular and technological advances on detection, monitoring and treatment.
Gianoukakis AG; Giannelli SM; Salameh WA; McPhaul LW
Mol Cell Endocrinol; 2011 Jan; 332(1-2):9-20. PubMed ID: 21094678
[TBL] [Abstract][Full Text] [Related]
2. [Gene abnormalities in thyroid cancer].
Namba H; Yamashita S
Nihon Rinsho; 2007 Nov; 65(11):1967-72. PubMed ID: 18018556
[TBL] [Abstract][Full Text] [Related]
3. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.
Banito A; Pinto AE; Espadinha C; Marques AR; Leite V
Clin Endocrinol (Oxf); 2007 Nov; 67(5):706-11. PubMed ID: 17651453
[TBL] [Abstract][Full Text] [Related]
4. ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome.
Tavares C; Melo M; Cameselle-Teijeiro JM; Soares P; Sobrinho-Simões M
Eur J Endocrinol; 2016 Apr; 174(4):R117-26. PubMed ID: 26510840
[TBL] [Abstract][Full Text] [Related]
5. Follicular thyroid carcinoma with an unusual glomeruloid pattern of growth.
Cameselle-Teijeiro J; Pardal F; Eloy C; Ruiz-Ponte C; Celestino R; Castro P; Soares P; Sobrinho-Simões M
Hum Pathol; 2008 Oct; 39(10):1540-7. PubMed ID: 18602667
[TBL] [Abstract][Full Text] [Related]
6. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
Nikiforova MN; Lynch RA; Biddinger PW; Alexander EK; Dorn GW; Tallini G; Kroll TG; Nikiforov YE
J Clin Endocrinol Metab; 2003 May; 88(5):2318-26. PubMed ID: 12727991
[TBL] [Abstract][Full Text] [Related]
7. Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARgamma) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor.
Lado-Abeal J; Celestino R; Bravo SB; Garcia-Rendueles ME; de la Calzada J; Castro I; Castro P; Espadinha C; Palos F; Soares P; Alvarez CV; Sobrinho-Simões M; Cameselle-Teijeiro J
Endocr Relat Cancer; 2010 Sep; 17(3):599-610. PubMed ID: 20427420
[TBL] [Abstract][Full Text] [Related]
8. [The advances of molecular pathology of follicular thyroid carcinoma].
Zhan Y; Cui QC
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):268-70. PubMed ID: 15256127
[No Abstract] [Full Text] [Related]
9. Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance".
Ohori NP; Nikiforova MN; Schoedel KE; LeBeau SO; Hodak SP; Seethala RR; Carty SE; Ogilvie JB; Yip L; Nikiforov YE
Cancer Cytopathol; 2010 Feb; 118(1):17-23. PubMed ID: 20099311
[TBL] [Abstract][Full Text] [Related]
10. Poorly Differentiated and Undifferentiated Thyroid Carcinomas.
Eloy C; Ferreira L; Salgado C; Soares P; Sobrinho-Simões M
Turk Patoloji Derg; 2015; 31 Suppl 1():48-59. PubMed ID: 26177317
[TBL] [Abstract][Full Text] [Related]
11. Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: cytogenetic and molecular analysis of 62 cases and correlation with histological findings.
Frau DV; Lai ML; Caria P; Dettori T; Coni P; Faa G; Morandi L; Tallini G; Vanni R
J Clin Endocrinol Metab; 2008 Jan; 93(1):177-81. PubMed ID: 17956956
[TBL] [Abstract][Full Text] [Related]
12. Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists.
Salajegheh A; Petcu EB; Smith RA; Lam AK
Postgrad Med J; 2008 Feb; 84(988):78-82. PubMed ID: 18322127
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnostics and predictors in thyroid cancer.
Nikiforova MN; Nikiforov YE
Thyroid; 2009 Dec; 19(12):1351-61. PubMed ID: 19895341
[TBL] [Abstract][Full Text] [Related]
14. Management of differentiated thyroid cancer of the follicular epithelium.
Pacini F
Ann Med; 2012 Nov; 44(7):651-5. PubMed ID: 21668295
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis.
Algeciras-Schimnich A; Milosevic D; McIver B; Flynn H; Reddi HV; Eberhardt NL; Grebe SK
Clin Chem; 2010 Mar; 56(3):391-8. PubMed ID: 20056739
[TBL] [Abstract][Full Text] [Related]
16. The fifteen percent issue in molecular-based diagnosis of follicular thyroid carcinoma.
Takano T
Pathol Int; 2011 Mar; 61(3):165-6. PubMed ID: 21355960
[No Abstract] [Full Text] [Related]
17. RAS mutations in thyroid cancer.
Howell GM; Hodak SP; Yip L
Oncologist; 2013; 18(8):926-32. PubMed ID: 23873720
[TBL] [Abstract][Full Text] [Related]
18. [Thyroid gland carcinoma].
Schmid KW
Praxis (Bern 1994); 1998 Mar; 87(11):367-74. PubMed ID: 9562812
[TBL] [Abstract][Full Text] [Related]
19. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
Castro P; Rebocho AP; Soares RJ; Magalhães J; Roque L; Trovisco V; Vieira de Castro I; Cardoso-de-Oliveira M; Fonseca E; Soares P; Sobrinho-Simões M
J Clin Endocrinol Metab; 2006 Jan; 91(1):213-20. PubMed ID: 16219715
[TBL] [Abstract][Full Text] [Related]
20. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.
Cheung L; Messina M; Gill A; Clarkson A; Learoyd D; Delbridge L; Wentworth J; Philips J; Clifton-Bligh R; Robinson BG
J Clin Endocrinol Metab; 2003 Jan; 88(1):354-7. PubMed ID: 12519876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]